Astrana Health Stock Fundamentals
| ASTH Stock | 33.48 0.01 0.03% |
Astrana Health fundamentals help investors to digest information that contributes to Astrana Health's financial success or failures. It also enables traders to predict the movement of Astrana Stock. The fundamental analysis module provides a way to measure Astrana Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Astrana Health stock.
As of now, Astrana Health's EBIT is increasing as compared to previous years. The Astrana Health's current Total Operating Expenses is estimated to increase to about 136.9 M, while Depreciation And Amortization is projected to decrease to under 8.9 M. Astrana | Select Account or Indicator |
Astrana Health Company Current Valuation Analysis
Astrana Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Astrana Health Current Valuation | 1.65 B |
Most of Astrana Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Astrana Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Astrana Current Valuation Historical Pattern
Today, most investors in Astrana Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Astrana Health's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Astrana Health current valuation as a starting point in their analysis.
Astrana Health Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Astrana Health has a Current Valuation of 1.65 B. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is notably lower than that of the firm.
Astrana Health Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Astrana Health's current stock value. Our valuation model uses many indicators to compare Astrana Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Astrana Health competition to find correlations between indicators driving Astrana Health's intrinsic value. More Info.Astrana Health is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.44 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Astrana Health is roughly 2.29 . As of now, Astrana Health's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Astrana Health's earnings, one of the primary drivers of an investment's value.Astrana Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Astrana Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Astrana Health could also be used in its relative valuation, which is a method of valuing Astrana Health by comparing valuation metrics of similar companies.Astrana Health is currently under evaluation in current valuation category among its peers.
Astrana Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Astrana Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Astrana Health's managers, analysts, and investors.Environmental | Governance | Social |
Astrana Fundamentals
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0449 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 1.65 B | ||||
| Shares Outstanding | 45.65 M | ||||
| Shares Owned By Insiders | 23.60 % | ||||
| Shares Owned By Institutions | 45.99 % | ||||
| Number Of Shares Shorted | 1.64 M | ||||
| Price To Book | 2.17 X | ||||
| Price To Sales | 0.89 X | ||||
| Revenue | 1.39 B | ||||
| Gross Profit | 199.48 M | ||||
| EBITDA | 123.69 M | ||||
| Net Income | 57.85 M | ||||
| Total Debt | 321.01 M | ||||
| Book Value Per Share | 14.75 X | ||||
| Cash Flow From Operations | 68.23 M | ||||
| Short Ratio | 4.86 X | ||||
| Earnings Per Share | 1.30 X | ||||
| Target Price | 64.5 | ||||
| Number Of Employees | 1.8 K | ||||
| Beta | 1.24 | ||||
| Market Capitalization | 1.53 B | ||||
| Total Asset | 933.36 M | ||||
| Retained Earnings | 243.13 M | ||||
| Working Capital | 242.83 M | ||||
| Net Asset | 933.36 M |
About Astrana Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Astrana Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Astrana Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Astrana Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 744 K | 706.8 K | |
| Total Revenue | 1.4 B | 1.5 B | |
| Cost Of Revenue | 1.2 B | 1.2 B | |
| Stock Based Compensation To Revenue | 0.02 | 0.01 | |
| Sales General And Administrative To Revenue | 0.08 | 0.05 | |
| Capex To Revenue | 0.02 | 0.02 | |
| Revenue Per Share | 29.69 | 31.17 | |
| Ebit Per Revenue | 0.06 | 0.05 |
Currently Active Assets on Macroaxis
When determining whether Astrana Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Astrana Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrana Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrana Health Stock:Check out Astrana Health Piotroski F Score and Astrana Health Altman Z Score analysis. For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.30) | Earnings Share 1.3 | Revenue Per Share 36.415 | Quarterly Revenue Growth 0.375 | Return On Assets 0.0449 |
The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Astrana Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Astrana Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astrana Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.